Actinium Pharmaceuticals Stock Price

0.00 (0.0%)
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
Level 1 Starter
Monthly Subscription
for only
VAT not included
Company Name Stock Ticker Symbol Market Type
Actinium Pharmaceuticals Inc ATNM AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 11.28 05:51:17
Close Price Low Price High Price Open Price Previous Close
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 11.28 USD

Actinium Pharmaceuticals Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 153.26M 13.59M 13.58M $ - $ - -4.60 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
563.61k $ - 0.00% - -

more financials information »

Actinium Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical ATNM Price Data

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week12.1812.364710.8011.59448,428-0.90-7.39%
1 Month9.3512.36478.5610.83288,5051.9320.64%
3 Months0.60512.36470.361.403,320,21410.681,764.46%
6 Months0.194512.36470.170.545526911,275,35211.095,699.49%
1 Year0.3012.36470.15060.4772637,326,51610.983,660.0%
3 Years0.7112.36470.15060.47959533,173,90110.571,488.73%
5 Years2.1012.36470.15060.58389942,131,7569.18437.14%

Actinium Pharmaceuticals Description

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Your Recent History
Actinium P..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.